Cargando…
Exploring Mannosylpurines as Copper Chelators and Cholinesterase Inhibitors with Potential for Alzheimer’s Disease
Alzheimer’s Disease (AD) is characterized by a progressive cholinergic neurotransmission imbalance, with a decrease of acetylcholinesterase (AChE) activity followed by a significant increase of butyrylcholinesterase (BChE) in the later AD stages. BChE activity is also crucial for the development of...
Autores principales: | Schino, Ignazio, Cantore, Mariangela, de Candia, Modesto, Altomare, Cosimo D., Maria, Catarina, Barros, João, Cachatra, Vasco, Calado, Patrícia, Shimizu, Karina, Freitas, Adilson A., Oliveira, Maria C., Ferreira, Maria J., Lopes, José N. C., Colabufo, Nicola A., Rauter, Amélia P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864808/ https://www.ncbi.nlm.nih.gov/pubmed/36678552 http://dx.doi.org/10.3390/ph16010054 |
Ejemplares similares
-
First-in-Class Isonipecotamide-Based Thrombin and Cholinesterase Dual Inhibitors with Potential for Alzheimer Disease
por: Purgatorio, Rosa, et al.
Publicado: (2021) -
Assessing the Role of a Malonamide Linker in the Design of Potent Dual Inhibitors of Factor Xa and Cholinesterases
por: Purgatorio, Rosa, et al.
Publicado: (2022) -
Chasing ChEs-MAO B Multi-Targeting 4-Aminomethyl-7-Benzyloxy-2H-Chromen-2-ones
por: Rullo, Mariagrazia, et al.
Publicado: (2019) -
Small and Innovative Molecules as New Strategy to Revert MDR
por: Zinzi, Laura, et al.
Publicado: (2014) -
ABC transporters in CSCs membranes as a novel target for treating tumor relapse
por: Zinzi, Laura, et al.
Publicado: (2014)